Patents Assigned to Phaeno Therapeutics Co., Ltd.
  • Crystal forms of thiazole compound and application thereof
    Patent number: 11964969
    Abstract: Disclosed by the present invention are a crystal form A of a compound represented by formula (I), a compound represented by formula (II) and a crystal form B thereof, as well as an application of the crystal form A of the compound represented by formula (I), the compound represented by formula (II) and the crystal form B thereof in the preparation of a drug for the treatment diseases associated with the herpes simplex virus.
    Type: Grant
    Filed: July 5, 2019
    Date of Patent: April 23, 2024
    Assignee: PHAENO THERAPEUTICS CO., LTD
    Inventors: Weihua Shi, Zhigan Jiang, Haiying He
  • Crystal form of 3,4-dihydrothieno[3,2-d]pyrimidine compound and preparation method thereof
    Patent number: 11174270
    Abstract: A crystal form A of a 3,4-dihydrothieno[3,2-d]pyrimidine compound (1), a preparation method therefor and an application thereof in the preparation of an anti-human cytomegalovirus (HCMV) drug.
    Type: Grant
    Filed: January 29, 2019
    Date of Patent: November 16, 2021
    Assignee: Phaeno Therapeutics Co., Ltd.
    Inventors: Jian Xiong, Jingjing Wang, Boyu Hu, Haizhong Tan, Kevin X. Chen, Jian Li, Shuhui Chen